Ivan Bergstein
2015
In 2015, Ivan Bergstein earned a total compensation of $3.7M as President and Chief Executive Officer at Stemline Therapeutics, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $385,214 |
|---|---|
| Non-Equity Incentive Plan | $400,000 |
| Option Awards | $1,583,405 |
| Salary | $517,500 |
| Stock Awards | $791,595 |
| Total | $3,677,714 |
Bergstein received $1.6M in option awards, accounting for 43% of the total pay in 2015.
Bergstein also received $385.2K in bonus, $400K in non-equity incentive plan, $517.5K in salary and $791.6K in stock awards.
Rankings
In 2015, Ivan Bergstein's compensation ranked 2,436th out of 13,638 executives tracked by ExecPay. In other words, Bergstein earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,436 out of 13,638 | 82nd |
Division Manufacturing | 868 out of 5,190 | 83rd |
Major group Chemicals And Allied Products | 314 out of 1,854 | 83rd |
Industry group Drugs | 248 out of 1,528 | 84th |
Industry Pharmaceutical Preparations | 194 out of 1,182 | 84th |
Source: SEC filing on May 1, 2017.
Bergstein's colleagues
We found three more compensation records of executives who worked with Ivan Bergstein at Stemline Therapeutics in 2015.